Capital Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-869,698
| Closed | -$59.9M | – | 79 |
|
2021
Q2 | $59.9M | Buy |
869,698
+3,641
| +0.4% | +$251K | 0.69% | 51 |
|
2021
Q1 | $56M | Buy |
866,057
+53,140
| +7% | +$3.43M | 0.66% | 47 |
|
2020
Q4 | $47.4M | Sell |
812,917
-63,043
| -7% | -$3.67M | 0.58% | 54 |
|
2020
Q3 | $55.4M | Sell |
875,960
-28,087
| -3% | -$1.77M | 0.75% | 43 |
|
2020
Q2 | $69.6M | Buy |
904,047
+34,439
| +4% | +$2.65M | 1.02% | 38 |
|
2020
Q1 | $65M | Buy |
869,608
+58,569
| +7% | +$4.38M | 1.09% | 34 |
|
2019
Q4 | $52.7M | Sell |
811,039
-33,584
| -4% | -$2.18M | 0.68% | 49 |
|
2019
Q3 | $53.5M | Sell |
844,623
-88,537
| -9% | -$5.61M | 0.74% | 51 |
|
2019
Q2 | $63M | Sell |
933,160
-3,551
| -0.4% | -$240K | 0.78% | 55 |
|
2019
Q1 | $60.8M | Sell |
936,711
-211,514
| -18% | -$13.7M | 0.77% | 53 |
|
2018
Q4 | $71.8M | Sell |
1,148,225
-210,795
| -16% | -$13.2M | 1.05% | 33 |
|
2018
Q3 | $105M | Sell |
1,359,020
-19,099
| -1% | -$1.47M | 1.31% | 21 |
|
2018
Q2 | $97.6M | Buy |
1,378,119
+163,196
| +13% | +$11.6M | 1.28% | 26 |
|
2018
Q1 | $91.6M | Buy |
1,214,923
+53,179
| +5% | +$4.01M | 1.24% | 25 |
|
2017
Q4 | $83.2M | Sell |
1,161,744
-35,984
| -3% | -$2.58M | 1.14% | 29 |
|
2017
Q3 | $97M | Buy |
1,197,728
+643,218
| +116% | +$52.1M | 1.24% | 23 |
|
2017
Q2 | $39.2M | Buy |
+554,510
| New | +$39.2M | 0.51% | 68 |
|